Abstract
Current advancements in medical sciences and pharmacogenomics are focusing on efficient, faster, and economic ways of drug delivery. On the other hand, big data analytics and machine learning are pushing the boundaries of human intelligence. Our aim is to bridge this gap between medical science and engineering by providing solutions that adhere to the requirements. Fields like remote robotic operations or artificial intelligence (AI) system for disease diagnosis and precision medicine are few that bridge this gap. Our proposed work in the field of precision medicine is an effort to contribute for making society healthier and more sustainable by reducing costs as well as reducing iatrogenic diseases by adopting technology advancements. The main focus of this survey paper is to understand the trends in field of biology, particularly in pharmacogenomics for better treatment of diseases by effective medication considering diabetes as an example. The paper also discusses issues related to application of machine learning in genomic data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adzhubei, I.A., et al.: A method and server for predicting damaging missense mutations. Nat. Methods 7, 248 EP (2010)
Albert, F.W., Kruglyak, L.: The role of regulatory variation in complex traits and disease. Nat. Rev. Genetics 16, 197 EP (2015)
Amarasingham, R., et al.: Clinical information technologies and inpatient outcomes: a multiple hospital study. Arch. Intern. Med. 169(2), 108–114 (2009)
Bland, J.S., et al.: Translating emerging science into individualized wellness. Adv. Med. 2017, 1–5 (2017)
Cheung, P.C., et al.: Childhood obesity incidence in the United States: a systematic review. Childhood Obes. (Print) 12(1), 1–11 (2016)
Cong, L., et al.: Multiplex genome engineering using crispr/cas systems. Science 339(6121), 819–823 (2013)
Cook, K.: Deep learning algorithms already hitting its limitations? (2019). https://www.houseofbots.com/news-detail/4463-1-deep-learning-algorithms-already-hitting-its-limitations
Dermitzakis, E.T., et al.: Evolutionary discrimination of mammalian conserved non-genic sequences (cngs). Science 302(5647), 1033–1035 (2003)
Evans, R.S.: Electronic health records: then, now, and in the future. Yearb. Med. Inform. 25(Suppl 1), S48–S61 (2016)
Farmer, A., Fox, R.: Diagnosis, classification, and treatment of diabetes. BMJ 342 (2011)
Gottesman, O., Kuivaniemi, H., Tromp, G., et al.: The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet. Med. 15(10), 761–771 (2013)
Harrow, J., Frankish, A., Gonzalez, E.A.: GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 22(9), 1760–1774 (2012)
Hollands, G.J., et al.: The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ (Clin. Res. Ed.) 352, i1102–i1102 (2016)
Huang, H., et al.: Predicting drug efficacy based on the integrated breast cancer pathway model. In: 2011 IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS), pp. 42–45, Dec 2011
Kaveeshwar, S.A., Cornwall, J.: The current state of diabetes mellitus in India. Australas. Med. J. 7(1), 45–48 (2014)
William, C., Knowler, M.D., et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)
Ledford, H.: End of cancer atlas prompts rethink: Geneticists debate whether focus should shift from sequencing genomes to analysing function. Nature 157, 128–129 (2015)
Lindblad-Toh, K., Garber, M., Zuk, O., Lin, M.F., Parker, B.J., et al.: A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478(7370), 476–482 (2011)
Marx, V.: The big challenges of big data. Nature 498, 255 EP (2013)
McCarty, C.A., et al.: The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 4(1), 13 (2011)
Meigs, J.B., et al.: Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359(21), 2208–2219 (2008)
Mudasir, A.W., et al.: Big data: issues, challenges and techniques in business intelligence (2016)
Musunuru, K., et al.: Interdisciplinary models for research and clinical endeavors in genomic medicine: a scientific statement from the American Heart Association. Circ. Genomic Precis. Med. 11(6) (2018)
Ohno-Machado, L., et al.: Genomics and electronic health record systems. Hum. Mol. Genet. 27(R1), R48–R55 (2018)
Oram, R.A., et al.: A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diab. Care 39(3), 337–344 (2016)
Parente, S.T., McCullough, J.S.: Perspective: health information technology and patient safety: evidence from panel data. Health Aff. 28(2), 357–360 (2009)
Pritchard, J.K., Przeworski, M.: Linkage disequilibrium in humans: models and data. Am. J. Hum. Genetics 69(1), 1–14 (2001)
Rajkomar, A., et al.: Scalable and accurate deep learning for electronic health records. NPJ Digit. Med. 1, 1–10 (2018)
Scott, R.A., et al.: Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genetics 44, 991 EP (2012)
Vassy, J.L., et al.: Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 63(6), 2172–2182 (2014)
Visscher, P.M., et al.: Biology, function, and translation. Am. J. Hum. Genetics 101(1), 5–22 (2017)
Xiong, H.Y., et al.: RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 347(6218), 1254806–1254806 (2015) (New York, N.Y.)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Aiman, S., Patil, K.K. (2021). From Generic to Custom: A Survey on Role of Machine Learning in Pharmacogenomics, Its Applications and Challenges. In: Bhateja, V., Peng, SL., Satapathy, S.C., Zhang, YD. (eds) Evolution in Computational Intelligence. Advances in Intelligent Systems and Computing, vol 1176. Springer, Singapore. https://doi.org/10.1007/978-981-15-5788-0_4
Download citation
DOI: https://doi.org/10.1007/978-981-15-5788-0_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5787-3
Online ISBN: 978-981-15-5788-0
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)